面对前列腺癌这一男性泌尿系统高发肿瘤，传统雄激素剥夺治疗 (ADT)虽是基石，但"大多数患者在接受ADT后约1年内进展为去势抵抗性前列腺癌" [1]。近年来，新型内分泌治疗药物的问世为临床带来革命性突破，显著延长患者生存期并改善生活质量。

SGLT2 inhibitors linked to lower hormone therapy failure in prostate cancer. Learn more about their potential role in improving treatment outcomes.

Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 ...

Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or ...

Probiotics and broccoli could help to slow the spread of prostate cancer, research suggests. Broccoli, turmeric, pomegranate, ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

Study finds gut-friendly probiotics, phytochemical-rich foods could help reduce or halt slow-growing prostate cancer ...

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...